| 3.69 Data as of May 17 |  -0.02 / -0.54%Today’s Change | 2.96 Today|||52-Week Range 5.50 | +16.40% Year-to-Date |
| Previous close | 3.71 |
| Today’s open | 3.73 |
| Day’s range | 3.66 - 3.78 |
| Volume | 349,579 |
| Average volume (3 months) | 671,242 |
| Market cap | $262.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +62.50% |
| Earnings growth (this year) | +102.39% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +10.52% |
| P/E ratio | NM |
| Price/Sales | 0.75 |
| Price/Book | 0.95 |
| Today’s change | Today’s % change | |
|---|---|---|
| AXDXAccelerate Diagnosti... | +0.06 | +0.76% |
| HBIOHarvard Bioscience I... | -0.03 | -0.57% |
| VRMLVermillion Inc | +0.05 | +1.94% |
| NEWPNewport Corp | +0.20 | +1.46% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | -$0.00 |
| Annual revenue (last year) | $295.6M |
| Annual profit (last year) | -$10.7M |
| Net profit margin | -3.62% |
Sector Health Technology |
Industry Biotechnology |
Chairman Stephen P. A. Fodor, PhD |
President, Chief Executive Officer & Director Franklin R. Witney, PhD |
Corporate headquarters Santa Clara, California |
.
